Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Paninvest Tbk (PNIN.JK)
Jakarta, ID
Established in 1973 and headquartered in Jakarta, Indonesia, PT Paninvest Tbk specializes in offering a comprehensive range of life insurance solutions throughout the country. Its product portfolio encompasses coverage for death, health, personal accident, various combined endowment schemes, unit-linked investment options, and additional insurance products. Beyond its core insurance business, the company provides services such as business consulting, management advisory, general administrative support, and expert guidance in archive management. Furthermore, PT Paninvest Tbk is also involved in the mutual funds sector. The entity, which was formerly known as Pt Panin Insurance Tbk, officially adopted its current name in May 2014.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.92% | -0.65% | -1.29% | -4.97% | -10.00% | -7.83% | -17.74% | -25.37% | +0.00% | +41.67% | +363.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-17.7% Q1'26: +41.2% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%-32.7% Q1'26: +123.3% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+101.1% Q1'26: -85.1% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+117.0% ★ Q1'26: +62.9% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+190.3% ★ Q1'26: +16.3% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.35× ★ Q1'26: 1.02× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akijat Lukito | Vice President Director & Company Secretary | — | male |
| Budi Setiawan | Head of Internal Audit Unit | — | male |
| Katty Sukamto | Head of Human Resources & General Affair | — | — |
| Paulus Indra Intan | President Director | — | male |
| Renda Halim | Head of Finance & Accounting | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PNIN.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
